2020
Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy
Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Affairs 2020, 40: 42-52. PMID: 33211536, PMCID: PMC7931245, DOI: 10.1377/hlthaff.2020.02054.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineVaccine efficacyCoronavirus disease 2019 (COVID-19) vaccinesSignificant vaccine hesitancyClinical outcomesClinical trialsVaccination programVaccine hesitancyEpidemic severityVaccineAuthorized vaccinesHealth officialsCumulative infectionsEfficacyVaccine productionDistribution programSeverityOutcomesUrgent needHospitalizationVaccinationInfectionTrialsGlobal efforts
2011
Vaccination Refusal: Ethics, Individual Rights, and the Common Good
Schwartz JL, Caplan AL. Vaccination Refusal: Ethics, Individual Rights, and the Common Good. Primary Care Clinics In Office Practice 2011, 38: 717-728. PMID: 22094142, DOI: 10.1016/j.pop.2011.07.009.Peer-Reviewed Original ResearchConceptsDoctor-patient relationshipEthical considerationsApparent recent increaseCommon goodHealth care providersIndividual rightsPublic healthVaccination recommendationsVaccination scheduleVaccination programCare providersVaccine refusalPossible responsesOutright resistanceEthicsParental attitudesHealthRightsPatientsRefusalVaccinePhysiciansGoodsEthics of vaccination programs
Schwartz JL, Caplan AL. Ethics of vaccination programs. Current Opinion In Virology 2011, 1: 263-267. PMID: 22440783, DOI: 10.1016/j.coviro.2011.05.009.Peer-Reviewed Original ResearchConceptsEthical challengesEthical issuesRisk controversiesEthicsFundamental principlesVaccination programUnique issuesHealth of individualsInfluenza vaccination campaignGlobal vaccination programsChildhood vaccinesIssuesVaccination activitiesVaccination campaignGlobal eradicationEventual designPublic healthControversyScientistsOngoing evaluationNationsPrinciplesRecent developmentsCommunityHealth
2007
Lessons from the Failure of Human Papillomavirus Vaccine State Requirements
Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Clinical Pharmacology & Therapeutics 2007, 82: 760-763. PMID: 17971822, DOI: 10.1038/sj.clpt.6100397.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildDrug CostsDrug IndustryFemaleHealth Services AccessibilityHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansLobbyingMandatory ProgramsMass VaccinationMichiganPapillomavirus InfectionsPapillomavirus VaccinesParentsPersonal AutonomyPoliticsPublic PolicySchoolsSexually Transmitted Diseases, ViralState GovernmentTexasTumor Virus InfectionsUnited StatesUterine Cervical NeoplasmsConceptsHuman papillomavirusCervical cancerCervical cancer prevention effortsHPV vaccination programCancer prevention effortsPublic health issueHPV vaccinationGenital wartsVaccination programCancer preventionEffective vaccineGreater prevalenceVaccinePrevention effortsHealth issuesConservative groupGlobal healthVaccinationCancerLicensurePapillomavirusMortalityPrevalenceSubtypesWarts